Journal List > J Korean Diabetes Assoc > v.30(5) > 1062396

Park, Kim, Kim, Nam, Noh, Ahn, Lee, Cha, Lim, Kim, and Lee: Relation between Cerebral Arterial Pulsatility and Insulin Resistance in Type 2 Diabetic Patients

Abstract

Background

Diabetic patients have a 3-fold risk for cerebrovascular disease compared with nondiabetic controls. The aim of the present study was to investigate the association of insulin resistance with pulsatility index (PI) of cerebral arteries in type 2 diabetic patients.

Methods

We compared a group of 90 patients with stroke free, type 2 diabetes and an age- and sex-matched control group of 45 healthy subjects without diabetes. Diabetic patients were divided into 3 groups according to the ISI (insulin sensitivity index). We evaluated PI of the middle cerebral artery (MCA) by transcranial Doppler ultrasonography (TCD) and insulin resistance determined by short insulin tolerance test.

Results

The PI was significantly higher in diabetic patients than that in healthy controls (P < 0.05), and also higher in patients with insulin resistance than that in insulin sensitive diabetic patients (P < 0.05). The PI of the MCA was significantly correlated with age (r= 0.465, P < 0.01), duration of diabetes (r = 0.264, P = 0.025), hypertension (r = 0.285, P = 0.015) and inversely correlated with insulin resistance (r = -0.359, P = 0.030). Multiple regression analysis was performed with PI as a dependent variable and insulin resistance as an independent variable along with known clinical risk factors. Age (β = 0.393, P < 0.01) and duration of diabetes (β = 0.274, P = 0.043) exhibited a significant independent contribution to PI.

Conclusions

PI might be useful markers of the detection of diabetic cerebrovascular changes and insulin resistance, measured with short insulin tolerance test, showed correlations with PI, but age and duration of diabetes contributed independently to the variability in the PI.

Figures and Tables

Table 1
Clinical Characteristics of Subjects
jkda-30-347-i001

Values are mean ± SD.

BMI, body mass index; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; MCA, middle cerebral artery; ICA, internal carotid artery; BA, basilar artery; PI, pulsatility index.

*P < 0.05 vs. controls.

P < 0.05 vs. insulin sensitive group.

Table 2
Mean MCA PI according to Diabetic Microvascular Complications
jkda-30-347-i002

Values are mean ± SD.

MCA, middle cerebral artery; PI, pulsatility index.

Table 3
Correlation Coefficients Determined by Simple Correlation between Mean MCA PI and Other Clinical Factors Possibly Affecting PI in Type 2 Diabetic Subjects.
jkda-30-347-i003

BMI, body mass index; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein cholesterol; MCA, middle cerebral artery; ICA, internal carotid artery; BA, basilar artery PI, pulsatility index.

Table 4
Multiple Regression Analysis of Clinical Factors Possibly Affecting Mean MCA PI in Type 2 Diabetic Subjects
jkda-30-347-i004

R2 = 0.416

MCA, middle cerebral artery; PI, pulsatility index.

References

1. Mankovsky BN, Metzger BE, Molitch ME, Biller J. Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complications. 1996. 10:228–242.
2. Grunett ML. Cerebrovascular disease; diabetes and cerebral atherosclerosis. Neurology. 1963. 13:486–491.
3. Meigs JB, Nathan DM, D'Agostino RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002. 25:1845–1850.
4. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997. 14:S7–S85.
5. Wakisaka M, Nagamachi S, Inoue K, Morotomi Y, Nunoi K, Fujishima M. Reduced regional cerebral blood flow in aged noninsulin-dependent diabetic patients with no history of cerebrovascular disease: evaluation by N-isopropyl-123I-p-iodoamphetamine with single photon emission computed tomography. J Diabetes Complications. 1990. 4:170–174.
6. Jimenez-Bonilla JF, Carril JM, Quirce R, Gomez-Barquin R, Amado JA, Gutierrez-Mendiguchia C. Assessment of cerebral blood flow in diabetic patients with no clinical history of neurological disease. Nucl Med Commun. 1996. 17:790–794.
7. Rodriguez G, Nobili F, Celestino MA, Francione S, Gulli G, Hassan K, Marenco S, Rosadini G, Cordera R. Regional cerebral blood flow and cerebrovascular reactivity in IDDM. Diabetes Care. 1993. 16:462–483.
8. Mortel KF, Meyer JS, Sims PA, McClintic K. Diabetes mellitus as a risk factor for stroke. South Med J. 1990. 83:904–911.
9. Grill V, Gutniak M, Bjorkman O, Lindqvist M, Stone-Elander S, Seitz RJ, Blomqvist G, Reichard P, Widen L. Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am J Physiol. 1990. 258:E813–E820.
10. Lee KY, Sohn YH, Baik JS, Kim GW, Kim JS. Arterial pulsatility as an index of cerebral microangiopathy in diabetes. Stroke. 2000. 31:1111–1115.
11. Kidwell CS, El-Saden S, Livshits Z, Martin NA, Glenn TC, Saver JL. Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease. J Neuroimaging. 2001. 11:229–235.
12. Bellner J, Romner B, Reinstrup P, Kristiansson KA, Ryding E, Brandt L. Transcranial Doppler sonography pulsatility index (PI) reflects intracranial pressure (ICP). Surg Neurol. 2004. 62:45–51.
13. Shen J, Xue Y, Wang Q. The application of transcranial Doppler in detecting diabetic cerebral macroangiopathy and microangiopathy. Zhonghua Nei Ke Za Zhi. 2002. 41:172–174.
14. Dikanovic M, Hozo I, Kokic S, Titlic M, Jandric M, Balen I, Kadojic D. Transcranial Doppler ultrasound assessment of intracranial hemodynamics in patients with type 2 diabetic mellitus. Ann Saudi Med. 2005. 25:486–488.
15. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI. Insulin resistance and risk for stroke. Neurology. 2002. 59:809–815.
16. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, McVeety JC, Horwitz RI. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology. 2003. 60:1447–1451.
17. Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, McVeety JC, Horwitz RI. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke. Stroke. 2003. 34:1431–1436.
18. Zunker P, Schick A, Buschmann HC, Georgiadis D, Nabavi DG, Edelmann M, Ringelstein EB. Hyperinsulinism and cerebral microangiopathy. Stroke. 1996. 27:219–223.
19. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972. 18:499–502.
20. Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non insulin treated NIDDM patients. Diabetes Care. 1998. 21:256–260.
21. Gosling RG, King DH. Arterial assessment by Dopplershift ultrasound. Proc R Soc Med. 1974. 67:447–449.
22. Legarth J, Nolsoe C. Doppler blood velocity waveforms and the relation to peripheral resistance in the brachial artery. J Ultrasound Med. 1990. 9:449–453.
23. Hassler W, Steinmetz H, Gawlowski J. Transcranial Doppler ultrasonography in raised intracranial pressure and in intracranial circulatory arrest. J Neurosurg. 1988. 68:745–751.
24. Tkac I, Troscak M, Javorsky M, Petrik R, Tomcova M. Increased intracranial arterial resistance in patients with type 2 diabetes mellitus. Wien Klin Wochenschr. 2001. 113:870–873.
25. Park JS, Kim CS, Nam JY, Kim DM, Cho MH, Park J, Ahn CW, Cha BS, Kim SK, Kim KR, Lee HC, Huh KB. Characteristics of type 2 diabetes in terms of insulin resistance in Korea. Yonsei Med J. 2005. 46:484–490.
26. G. Neil T, Athena H, Brian T, Chris L, Jullian C, John S, Jean W, Edith L. Increasing insulin resistance contributes to worsening glycaemic and lipid profiles in older chinese subjects. Diabetes Res Clin Pract. 2004. 64:123–128.
27. Lippera S, Gregorio F, Ceravolo MG, Lagalla G, Provinciali L. Diabetic retinopathy and cerebral hemodynamic impairment in type II diabetes. Eur J Ophthalmol. 1997. 7:156–162.
28. Cho SJ, Sohn YH, Kim GW, Kim JS. Blood flow velocity changes in the middle cerebral artery as an index of the chronicity of hypertension. J Neurol Sci. 1997. 150:77–80.
29. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1984. 6:45–86.
30. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V. Estimates of in vivo insulin action in man; comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab. 1989. 68:374–378.
35. Kee DB, Wood JH. Wood JH, editor. Influence of blood rheology on cerebral circulation. Cerebral Blood Flow: Physiologic and clinical aspects. 1988. New York: McGraw-Hill Book Co;173–185.
36. Brass L, Pavlakis S, De Vivo D, Piomelli S, Mohr JP. Transcranial Doppler measurements of the middle cerebral artery. Effect of hematocrit. Stroke. 1988. 19:1466–1469.
37. Ameriso SF, Paganini-Hill A, Meiselman HJ, Fisher M. Correlates of middle cerebral artery blood velocity in the elderly. Stroke. 1990. 21:1579–1583.
TOOLS
Similar articles